公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2014 | Dystrophin is a tumor suppressor in human cancers with myogenic programs | Wang Y.; Marino-Enriquez A.; Bennett R.R.; Zhu M.; Shen Y.; Eilers G.; JEN-CHIEH LEE ; Henze J.; Fletcher B.S.; Gu Z.; Fox E.A.; Antonescu C.R.; Fletcher C.D.M.; Guo X.; Raut C.P.; Demetri G.D.; Van De Rijn M.; Ordog T.; Kunkel L.M.; Fletcher J.A. | Nature Genetics | 125 | 120 | |
2012 | Integrating bioinformatics and clinicopathological research of gastrointestinal stromal tumors: Identification of aurora kinase a as a poor risk marker | Yen C.-C.; Yeh C.-N.; Cheng C.-T.; Jung S.-M.; Huang S.-C.; Chang T.-W.; Jan Y.-Y.; Tzeng C.-H.; Chao T.-C.; Chen Y.-Y.; CHING-YAO YANG ; Ho C.-L.; Fletcher J.A. | Annals of Surgical Oncology | 23 | 19 | |
2015 | KRAS and KIT gatekeeper mutations confer polyclonal primary imatinib resistance in GI stromal tumors: Relevance of concomitant phosphatidylinositol 3-kinase/AKT dysregulation | Serrano C.; Wang Y.; Mariño-Enríquez A.; JEN-CHIEH LEE ; Ravegnini G.; Morgan J.A.; Bertagnolli M.M.; Beadling C.; Demetri G.D.; Corless C.L.; Heinrich M.C.; Fletcher J.A. | Journal of Clinical Oncology | 45 | 42 | |
2021 | Loss of SFRP1 expression is a key progression event in gastrointestinal stromal tumor pathogenesis | Liang C.-W.; CHING-YAO YANG ; Flavin R.; Fletcher J.A.; TZU-PIN LU ; I-RUE LAI ; Li Y.-I.; YIH-LEONG CHANG ; JEN-CHIEH LEE | Human Pathology | 6 | 5 |